| | | | | |

Lung-Sparing Surgery and Mesothelioma Survival

1884742_Surgeon2When it comes to the mesothelioma surgery known as pleurectomy/decortication (P/D), not all techniques are created equal.

A new report in the European Journal of Cardio-Thoracic Surgery finds that two of the three primary P/D approaches offer a significant mesothelioma survival advantage over the third.

Setting up the Mesothelioma Surgery Study

Thoracic surgeons from 11 Italian institutions reviewed the cases of 314 pleural mesothelioma patients who had P/D surgery to remove the pleural membrane and certain other at-risk tissues between January 2011 and October 2014.

The characteristics of the study participants were in line with worldwide mesothelioma statistics. There were almost four times as many male mesothelioma patients as there were female, most had the epithelioid type of the mesothelioma and the median age at the time of operation was 67.8.

Sixty-two percent of patients were diagnosed with Stage III mesothelioma. Fifty-seven percent of the mesothelioma patients received chemotherapy prior to P/D surgery.

Three Types of P/D Surgery for Mesothelioma

Mesothelioma surgeries fall into two broad categories – extrapleural pneumonectomy (EPP), which includes the removal of the diseased lung, and P/D, which removes the pleura but leaves the lungs in place.

Although many mesothelioma experts are now favoring P/D over EPP because of its lower risk of complications and death, the two approaches are hard to compare side-by-side because there are multiple ways to perform P/D.

In the new Italian study, the researchers attempted to compare the three primary P/D approaches: extended P/D/, P/D, and partial P/D.

One hundred and sixty-two of the study participants underwent extended P/D (also known as radical P/D) which includes removal of the pleura, the pericardium around the heart. and the diaphragm as well as other tissues.

Another 115 pleural mesothelioma patients underwent a standard P/D surgery which leaves more tissues in place. Just 37 patients (11.8%) had partial P/D which involves removal of the pleura but does not attempt to remove all of the tumor tissue.

Mesothelioma Survival After P/D Surgery

After analyzing the results, the researchers concluded that only P/D and extended P/D impacted mesothelioma survival.

“Whether the P/D is extended or not, it shows similarly good outcomes in terms of early results and survival rate,” writes study author Giuseppe Marulli of the University of Padova. “In contrast, a partial pleurectomy, which leave gross tumour behind, has no impact on survival.”

While partial P/D may not extend survival, it may still have a role to play in mesothelioma treatment. The MesoVATS trial, a multicenter study that included 175 patients with malignant pleural mesothelioma and pleural effusions, found that partial pleurectomy significantly improved patients’ quality of life by effectively controlling their excess lung fluid.

Source:

Marulli, G, et al, “Pleurectomy–decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study”, April 12, 2017, European Journal of Cardio-Thoracic Surgery, Epub ahead of print

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…